FDA Enforcement Class I Ongoing

CereLink ICP Monitor; Catalog No. 826820, 826820P. Intracranial pressure monitor.

Recall: Z-1395-2022 · Reported August 3, 2022

Enforcement

Recall Number
Z-1395-2022
Event ID
90457
Classification
Class I
Status
Ongoing
Product Type
Devices
Firm
Integra LifeSciences Corp.
Voluntary / Mandated
Voluntary: Firm initiated
Initial Notification
Letter
Report Date
August 3, 2022
Initiation Date
June 22, 2022
Classification Date
July 22, 2022
Address
1100 Campus Rd, Princeton, NJ, 08540-6650, United States

Description

CereLink ICP Monitor; Catalog No. 826820, 826820P. Intracranial pressure monitor.

Reason

Integra has received complaints associated with ICP readings drifting to -50 mmHg (out-of-range) and may manifest an error message "sensor or extension cable failure!" The firm has found that this is caused by electrical interference from a component of the monitor's circuit board and from the environment.

Code Info

UDI-DI- 10381780533778; All serial numbers.

Distribution

Worldwide Distribution: US nationwide, Australia, New Zealand, Canada, Hong Kong, Pakistan, Georgia, Saudi Arabia, Israel, South Africa, United Arab Emirates, Austria, Belgium, Czech Republic, Denmark, Estonia, Finland, France, Germany, Great Britain, Greece, Ireland, Italy, Latvia, Lithuania, Netherlands, Norway, Portugal, Switzerland, Spain, Sweden, Slovakia, and United Kingdom.

Quantity

1,210 units